NovoLog® Mix 70/30 has 60% unrestricted access.1,a,b,c
Broad access: co-pay and formulary coverage for your patients
Cost and coverage don't need to be barriers for your patients on premix insulin—even those patients covered by Medicare Part D.
Check your patients’ formulary coverage in just 2 steps
More units. Same co-pay.
One box of NovoLog® Mix 70/30 FlexPens® provides 50% more insulin than a vial of human premix insulin for the same co-pay on most managed care plans.d
Share the Novo Nordisk Instant Savings Card with eligible patients
Request samples to start patients on NovoLog® Mix 70/30
aIntended as a guide. Lower acquisition costs alone do not necessarily reflect a cost advantage in the outcome of the condition treated because there are other variables that affect relative costs. Formulary status is subject to change.
bManaged care plans only. Does not include Medicaid. Multiple products within the same therapeutic class may be considered preferred and on the same tier.
cFormulary data are provided by Fingertip Formulary® and are current as of April 2017. Because formularies do change and many health plans offer more than one formulary, please check with the health plan directly to confirm coverage for individual patients.
dOne box of 5 NovoLog® Mix 70/30 FlexPens® equals 1500 units versus 1 vial with 1000 units.